Data for HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Organisation | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|
| NORTH EAST STRATEGIC HEALTH … | 5564 | 6437 | 86.4% | 100 |
| LONDON STRATEGIC HEALTH AUTHORITY | 8980 | 10690 | 84.0% | 90 |
| YORKSHIRE AND THE HUMBER … | 9061 | 10921 | 83.0% | 80 |
| NORTH WEST STRATEGIC HEALTH … | 14765 | 17816 | 82.9% | 70 |
| UK | 110947 | 134538 | 82.5% | |
| EAST MIDLANDS STRATEGIC HEALTH … | 9330 | 11328 | 82.4% | 60 |
| NHS England | 88962 | 108106 | 82.3% | |
| SOUTH WEST STRATEGIC HEALTH … | 9978 | 12216 | 81.7% | 50 |
| SOUTH CENTRAL STRATEGIC HEALTH … | 5926 | 7263 | 81.6% | 40 |
| SOUTH EAST COAST STRATEGIC … | 6093 | 7470 | 81.6% | 30 |
| WEST MIDLANDS STRATEGIC HEALTH … | 10106 | 12499 | 80.8% | 20 |
| EAST OF ENGLAND STRATEGIC … | 9159 | 11466 | 79.9% | 10 |
